Research
Study explores potential antiviral treatment approach for long COVID
The Brief
- Researchers reported encouraging results from a new feasibility study on a potential long COVID treatment.
- The study explores an antiviral treatment approach for long COVID.
- Source material is a short summary; details on the drug, sample size and outcomes are not provided.
Why it matters
Long COVID lacks proven treatments, so early feasibility work on antiviral approaches is of interest to clinicians and researchers, though a feasibility study does not establish efficacy.
Who’s affected
- patients with long COVID
- clinicians and researchers in infectious disease
- #long covid
- #antiviral
- #clinical trial
- #feasibility study
- #infectious disease
Researchers have reported encouraging results from a new feasibility study looking to find a potential treatment for long COVID.